🇺🇸 FDA
Patent

US 8093354

Process for preparing glycopeptide phosphonate derivatives

granted A61KA61K38/00A61P

Quick answer

US patent 8093354 (Process for preparing glycopeptide phosphonate derivatives) held by Theravance, Inc. expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/00, A61P, A61P31/00, A61P31/04